sentence: A highly concentrated ( 20 % ) immunoglobulin ( Ig ) G preparation for subcutaneous administration ( IGSC 20 % ) , would offer a new option for antibody replacement therapy in patients with primary immunodeficiency diseases ( PIDD ) .